<sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of Amino Acid Conjugates of Terpenoids
-
- Ukiya Motohiko
- 作成者
-
- Sekine Tomoyuki
- 作成者
-
- Shimizu Naoto
- 作成者
-
- Akazawa Hiroyuki
- 作成者
-
- Tanigawa Minoru
- 作成者
-
- Suzuki Yusuke
- 作成者
メタデータ
- 最終更新日
- 2023-05-31
- サイズ
-
- 2.86MB
- バージョン
- 3.0
- 著作権
-
- CC BY 4.0
- 公開日
- 2023-04-04
- 公開者
- JAPAN OIL CHEMISTS' SOCIETY
抄録
<p> </p> <p>1H-NMR, 13C-NMR, and HRMS of ent-16β,19-dihydroxybeyerane di-O-glycine conjugate (compound 5)…p.1–2</p> <p>1H-NMR, 13C-NMR, and HRMS of ent-16β,19-dihydroxybeyerane di-O-l-alanine conjugate (compound 6)…p.3–4</p> <p>1H-NMR, 13C-NMR, and HRMS of ent-16β,19-dihydroxybeyerane di-O-alanine conjugate (compound 7)…p.5–6</p> <p>1H-NMR, 13C-NMR, and HRMS of ent-16β,19-dihydroxybeyerane di-O-L-isoleucine conjugate (compound 8)…p.7–8</p> <p>1H-NMR, 13C-NMR, and HRMS of ent-16β,19-dihydroxybeyerane di-O-D-isoleucine conjugate (compound 9)…p.9–10</p> <p>1H-NMR, 13C-NMR, and HRMS of ent-16β,19-dihydroxybeyerane di-O-L-valine conjugate (compound 10)…p.11–12</p> <p>1H-NMR, 13C-NMR, and HRMS of ent-16β,19-dihydroxybeyerane di-O-D-valine conjugate (compound 11)…p.13–14</p> <p>1H-NMR, 13C-NMR, and HRMS of ent-16β,19-dihydroxybeyerane di-O-L-phenylalanine conjugate (compound12)…p.15–16</p> <p>1H-NMR, 13C-NMR, and HRMS of ent-16β,19-dihydroxybeyerane di-O-D-phenylalanine conjugate (compound 13)…p.17–18</p> <p>1H-NMR, 13C-NMR, and HRMS of ent-16β,19-Dihydroxybeyerane di-O-succinate (compound 14)…p.19–20</p> <p>1H-NMR, 13C-NMR, and HRMS of ent-16β,19-Dihydroxybeyerane N,N-dimethylglycine conjugate (compound 15)…p.21–22</p> <p>1H-NMR, 13C-NMR, and HRMS of erythrodiol di-O-glycine conjugate (compound 19)…p.23–24</p> <p>1H-NMR, 13C-NMR, and HRMS of erythrodiol di-O-L-alanine conjugate (compound 20)…p.25–26</p> <p>1H-NMR, 13C-NMR, and HRMS of erythrodiol di-O-D-alanine conjugate (compound 21)…p.27–28</p> <p>1H-NMR, 13C-NMR, and HRMS of erythrodiol di-O-L-leucine conjugate (compound 22)…p.29–30</p> <p>1H-NMR, 13C-NMR, and HRMS of erythrodiol di-O-D-leucine conjugate (compound 23)…p.31–32</p> <p>1H-NMR, 13C-NMR, and HRMS of erythrodiol di-O-L-valine conjugate (compound 24)…p.33–34</p> <p>1H-NMR, 13C-NMR, and HRMS of erythrodiol di-O-D-valine conjugate (compound 25)…p.35–36</p> <p>1H-NMR, 13C-NMR, and HRMS of erythrodiol di-O-L-phenylalanine conjugate (compound 26)…p.37–38</p> <p>1H-NMR, 13C-NMR, and HRMS of erythrodiol di-O-D-phenylalanine conjugate (compound 27)…p.39–40</p> <p>1H-NMR, 13C-NMR, and HRMS of Erythrodiol di-O-succinate (compound 28)…p.41–42</p> <p>1H-NMR, 13C-NMR, and HRMS of Erythrodiol N,N-dimethylglycine conjugate (compound 29)…p.43–44</p> <p>Apoptosis inducing effect by ent-16β,19-dihydroxybeyerane di-O-L-isoleucine conjugate (compound 8)…p.45–46</p>
